Sintilimab in Combination With Gemcitabine and Platinum-Based Chemotherapy as First-Line Therapy for Advanced or Metastatic Squamous NSCLC
Clinical trial NCT03629925 · COMPLETED
Trial details
- NCT number
- NCT03629925
- Sponsor
- Innovent Biologics (Suzhou) Co. Ltd.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2018-09-28
- Primary completion
- 2020-03-25
- Enrollment
- 357
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.